| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.0M | -2.6% |
| Cost of Revenue | $1.3M | -63.7% |
| Gross Profit | $14.7M | +14.0% |
| R&D Expense | $6.0M | +9.7% |
| SG&A Expense | $12.4M | +7.2% |
| Operating Income | -$3.7M | +10.6% |
| Pre-tax Income | -$3.7M | +50.2% |
| Income Tax | $124K | — |
| Net Income | -$3.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -61.9% |
| Accounts Receivable | $2.6M | +20.3% |
| Current Assets | $13.3M | -19.2% |
| Total Assets | $22.5M | -12.7% |
| Current Liabilities | $3.9M | -12.3% |
| Total Liabilities | $3.9M | -12.5% |
| Stockholders' Equity | $18.5M | -12.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | -411.8% |
| Capital Expenditures | $192K | -71.0% |
| Investing Cash Flow | -$5.1M | -666.2% |
| Financing Cash Flow | $97K | +27.6% |
| Free Cash Flow | -$3.7M | -908.8% |
| +7.1% |
| EPS (Basic) | -$0.20 | +9.1% |
| EPS (Diluted) | -$0.20 | +9.1% |